MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering ...

Variable frequency drives (VFDs) are used in many industrial applications to improve energy efficiency and provide precise ...

The Cuyahoga County Medical Examiner's Office is working to determine the identity. Collapse: Poll Delivers Blow to Trump Researchers uncover Titanic's tragic end using 3D digital scan ...

“Dosing the first patient in our global Phase 3 program is a major advancement as we work to deliver a differentiated, next-generation therapy for HCV,” said Jean-Pierre Sommadossi ...

As the second phase of the Silica City project is set to ... Canal No 2 Polder on the West Bank of Demerara (WBD) in Region Three. Silica City, located along the Soesdyke-Linden Highway, is ...

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

said Morgan Evans, CEO of Agitated Solutions. “This IND clearance is a significant milestone, allowing us to begin our Phase 3 trial aimed at demonstrating a more consistent and simple method to ...

Cassava Sciences will discontinue developing simufilam for mild to moderate Alzheimer’s disease by the end of the second quarter of this year after the experimental treatment failed to meet key Phase ...

Tasman's pivotal Phase 3 ROCKET Program is set to begin patient enrollment in the second half of 2025. This program will generate crucial data on the safety, onset of effect, and durability of a ...

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma. The FDA has granted clearance to initiate a global ...

We believe our product can overcome this limitation, offering a safer and more controlled solution." Tasman's pivotal Phase 3 ROCKET Program is set to begin patient enrollment in the second half of ...